Artiva Biotherapeutics, Inc. ARTV Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Artiva Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ShortTermInvestments.
The official record: Artiva Biotherapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Artiva Biotherapeutics, Inc.'s short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Artiva Biotherapeutics, Inc.'s short-term investments?
- Artiva Biotherapeutics, Inc. (ARTV) reported short-term investments of $65.83M in Q1 2026.
- How has Artiva Biotherapeutics, Inc.'s short-term investments changed year-over-year?
- Artiva Biotherapeutics, Inc.'s short-term investments decreased by 51.4% year-over-year, from $135.56M to $65.83M.
- What is the long-term trend for Artiva Biotherapeutics, Inc.'s short-term investments?
- Over 2 years (2023 to 2025), Artiva Biotherapeutics, Inc.'s short-term investments has grown at a 86.1% compound annual growth rate (CAGR), from $23.47M to $81.31M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.